Business
Although we are able to license some of our technologies in their current stage of development, we cannot assure that we will be able to develop new products or enhancements to our existing products in order to remain competitive.
Myseum, Inc.: Revenue grew 26.1% to $0.55K from $0.436K. Net loss narrowed to $2.607M from $4.239M. Free cash flow outflow narrowed to $4.272M from $4.438M. Operating margin contracted 26031002 bps to -998192.36%. Myseum, Inc.'s annual comparison also shows stock compensation grew faster than revenue; the manipulation screen is flagged and should be investigated as a warning rather than treated as proof; the balance-sheet screen falls in the distress range and requires business-model context; the earnings-quality screen is distress.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 26.1% to $0.55K from $0.436KOK
- Profitability — Net loss narrowed to $2.607M from $4.239MOK
- Cash flow — Free cash flow outflow narrowed to $4.272M from $4.438MOK
- Margins — Operating margin contracted 26031002 bps to -998192.36%Watch
- Accounting — Controls ineffective; going-concern warningWatch
- Insiders — 5 purchases and 0 salesOK
Latest filings
- 10-Q · Quarterly report2026-08-14
- 8-K · Company announcement2026-08-12
- 8-K · Company announcement2026-08-06
- 8-K · Company announcement2026-07-22
- DEF 14A · Annual proxy (pay & governance)2026-06-23
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Myseum.AI, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.